Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256890 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Blood Pressure Reduction: Stage 2a RCT
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT03256890: Completed NA study, sponsored by Brown University.
NCT03256890 is a NA study that has completed, run by Brown University. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03256890, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
The primary aim is to evaluate impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care control on systolic blood pressure at 6 months, via a randomized controlled trial.
Primary Outcome
Directly assessed as mean of second and third blood pressure readings
Interventions
- OTHER Enhanced Usual Care Control
- BEHAVIORAL MB-BP Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
What the finished NCT03256890 record still lists
NCT03256890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care Control is the first listed.
NCT03256890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03256890 about?
NCT03256890 is a clinical study titled "Mindfulness-Based Blood Pressure Reduction: Stage 2a RCT". The primary aim is to evaluate impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care control on systolic blood pressure at 6 months, via a randomized controlled trial.
What is the current status of trial NCT03256890?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2017-06-13. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT03256890?
The interventions under investigation include: Enhanced Usual Care Control (OTHER), MB-BP Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03256890?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03256890's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI